Caplin Point Laboratories informs about press release

01 Jan 2026 Evaluate

Caplin Point Laboratories has informed that it enclosed a Press Release regarding acquisition of ten approved Abbreviated New Drug Applications (ANDAs) for Injectable and Opthalmic products from a leading Multinational Generic product manufacturing company.

The above information is a part of company’s filings submitted to BSE.


Caplin Point Lab Share Price

1505.15 -52.05 (-3.34%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×